Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in human in vitro differentiated macrophages

Biochemical Pharmacology

Volumn 59, Issue 2, 2000, Pages 187-194

  Huang, Zai Feng ^a   Massey, John B ^a   Via, David P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclooxygenase 2; Human primary macrophages; Interleukin 1 ; mRNA stability; Tumor necrosis factor

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CYCLOOXYGENASE 2; DRUG SYNERGISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN-1; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA STABILITY; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033991143     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00312-3     Document Type: Article

References (39)

1. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 271:1996;33157-33160.
2. Gou Q., Liu C.H., Ben-Av P., Hla T. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem Biophys Res Commun. 242:1998;508-512.
3. Endo T., Ogushi F., Sone S. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-γ J Immunol. 156:1996;2240-2246.
4. Arias-Negrete S., Keller K., Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun. 208:1995;582-589.
5. Reise J., Hoff T., Nordhoff A., DeWitt D.L., Resch K., Kaever V. Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J Leukoc Biol. 55:1994;476-482.
6. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest. 95:1995;1669-1675.
7. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
8. Appleby S.B., Ristimaki A., Neilson K., Narko K., Hla T. Structure of the human cyclooxygenase-2 gene. Biochem J. 302:1994;723-727.
9. Srivastava S.K., Tetsuka T., Daphna-Iken D., Morrison A.R. IL-1β stabilizes COX II mRNA in renal mesangial cells Role of 3′-untranslated region. Am J Physiol. 267:1994;F504-F508.
10. Ristimäki A., Garfinkel S., Wessendorf J., Maciag T., Hla T. Induction of cyclooxygenase-2 by interleukin-1α. Evidence for post-transcriptional regulation. J Biol Chem. 269:1994;11769-11775.
11. Slater D., Berger L., Moore G., Bennett P. Implication of mRNA binding proteins in the regulation of cyclooxygenase in human amnion at term. Biochem Biophys Res Commun. 203:1994;67-71.
12. Rimarachin J.A., Jacobson J.A., Szabo P., Maclouf J., Creminon C., Weksler B.B. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler Thromb. 14:1994;1021-1031.
13. Barnes P.J. Nuclear factor-κB. Int J Biochem Cell Biol. 29:1997;867-870.
14. Jobin C., Morteau O., Han D.S., Sartor R.B. Specific NF-κB blockade selectively inhibits tumour necrosis factor-α-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology. 95:1998;537-543.
15. Newton R., Stevens D.A., Hart L.A., Lindsay M., Adcock I.M., Barnes P.J. Superinduction of COX-2 mRNA by cycloheximide and interleukin-1β involves increased transcription and correlates with increased NF-κB and JNK activation. FEBS Lett. 418:1997;135-138.
16. Dougherty G.J., McBride W.H. Monocyte differentiation in vitro. Zembala M., Asherson G.I. Human Monocytes. 1989;49-58 Academic Press, San Diego.
17. Fogelman A.M., Elahi F., Sykes K., Van Lenten B.J., Territo M.C., Berliner J.A. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 29:1988;1243-1247.
18. Fogelman A.M., Haberland M.E., Seager J., Hokom M., Edwards P.A. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res. 22:1981;1131-1141.
19. Farrell RE Jr, RNA Methodologies: A Laboratory Guide for Isolation and Characterization, pp. 235-263. Academic Press, San Diego, 1993.
20. Fenton M.J. Review Transcriptional and post-transcriptional regulation of interleukin 1 gene expression. Int J Immunopharmacol. 14:1992;401-411.
21. Varesio L., Espinoza-Delgado I., Gusella L., Cox G.W., Melillo G., Musso T., Bosco M.C. Role of cytokines in the activation of monocytes. Aggarwal B.B., Puri R. Human Cytokines Their Role in Disease and Therapy. 1994;55-69 Blackwell Science, Ann Arbor, MI.
22. Tamm I., Sehgal P. Halobenzimidazole ribosides and RNA synthesis of cells and viruses. Adv Virus Res. 22:1978;187-258.
23. Altman M., Trachsel M. Regulation of translation initiation and modulation of cellular physiology. Trends Biochem Sci. 18:1993;429-432.
24. Melefors O., Hentze M.W. Translational regulation by mRNA/protein interactions in eukaryotic cells ferritin and beyond. Bioessays. 15:1993;85-90.
25. McGowan K.M., Police S., Winslow J.W., Pekala P.H. Tumor necrosis factor-α regulation of glucose transporter (GLUT1) mRNA turnover. J Biol Chem. 272:1997;1331-1337.
26. Edwards D.R., Mahadevan L.C. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms Lack of evidence for labile repressors. EMBO J. 11:1992;2415-2424.
27. Ridley S.H., Dean J.L., Sarsfield S.J., Brook M., Clark A.R., Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439:1998;75-80.
28. Amano Y., Lee S.W., Allison A.C. Inhibition by glucocorticoids of the formation of interleukin-1α, interleukin-1β, and interleukin-6 Mediation by decreased mRNA stability. Mol Pharmacol. 43:1993;176-182.
29. 2 production in resting macrophages. Biochem Biophys Res Commun. 136:1986;94-101.
30. Grewe M., Gausling R., Gyufko K., Hoffmann R., Decker K. Regulation of the mRNA expression for tumor necrosis factor-α in rat liver macrophages. J Hepatol. 20:1994;811-818.
31. Smith J.G., Magee D.M., Williams D.M., Graybill J.R. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J Infect Dis. 162:1990;1349-1353.
32. Malek N.P., Pluempe J., Kubicka S., Manns M.P., Trautwein C. Molecular mechanisms of TNF receptor-mediated signaling. Recent Results Cancer Res. 147:1998;97-106.
33. Natoli G., Costanzo A., Guido F., Moretti F., Levrero M. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signaling. Biochem Pharmacol. 56:1998;915-920.
34. William R., Watson G., Rotstein O.D., Parodo J., Bitar R., Marshall J.C. The IL-1β-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1β J Immunol. 161:1998;957-962.
35. 2-dependent mechanism of portal venous transfusion-induced immunosuppression? J Surg Res. 78:1998;37-41.
36. 2 induces apoptosis in immature normal and malignant B lymphocytes. Clin Immunol Immunopathol. 63:1992;221-229.
37. 2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. Adv Prostaglandin Thromboxane Leukot Res. 23:1995;457-459.
38. von Knethen A., Brune B. Cyclooxygenase-2 An essential regulator of NO-mediated apoptosis. FASEB J. 11:1997;887-895.
39. 2 and nitric oxide in cell death in J774 murine macrophages. Eur J Pharmacol. 349:1998;307-315.